| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |